MINNEAPOLIS, Aug. 4, 2022
/PRNewswire/ --
Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors
has decided to pay a dividend of $0.32 per share for the quarter
ended June 30, 2022. The quarterly dividend
will be payable August 29,
2022, to all common shareholders of
record on August 15, 2022.
Future cash dividends will be considered by the Board of Directors
on a quarterly basis.
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences
company providing innovative
tools and bioactive
reagents for the research
and clinical diagnostic communities. Bio-Techne products
assist scientific investigations into biological processes
and the nature and
progress of specific diseases. They
aid in drug discovery efforts
and provide the means for accurate clinical
tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.1
billion in net sales in fiscal 2022 and
has approximately 3,000 employees worldwide. For more
information on Bio-Techne and its brands, please visit www.bio
techne.com.
Forward Looking Statements:
Our press releases may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act. Such
statements involve risks and uncertainties that may affect the
actual results of operations. Forward looking statements in this
press release include statements regarding potential future
repurchase of Bio-Techne common stock. The following important
factors, among others, have affected and, in the future, could
affect the Company's actual results and future share price: the
effect of new branding and marketing initiatives, the integration
of new businesses and leadership, the introduction and acceptance
of new products, the funding and focus of the types of research by
the Company's customers, the impact of the growing number of
producers of biotechnology research products and related price
competition, general economic conditions, customer site closures or
supply chain issues resulting from the COVID-19 pandemic, the
impact of currency exchange rate fluctuations, and the costs and
results of research and product development efforts of the Company
and of companies in which the Company has invested or with which it
has formed strategic relationships.
For additional information concerning such factors, see the
section titled "Risk Factors" in the Company's annual report on
Form 10-K and quarterly reports on Form 10-Q as filed with the
Securities and Exchange Commission. We undertake no obligation to
update or revise any forward-looking statements we make in our
press releases due to new information or future events. Investors
are cautioned not to place undue emphasis on these statements.
Contact: David Clair, Vice
President, Investor Relations
David.Clair@bio-techne.com
612-656-4416
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-declares-dividend-301599814.html
SOURCE Bio-Techne Corporation